Emrelis (telisotuzumab vedotin-tllv)

ADC for lung cancer

SKU: emrelis-telisotuzumab Category: Lung Cancer Tags: adc, lung-cancer, oncology

Description

Emrelis (telisotuzumab vedotin-tllv) is an antibody-drug conjugate used for non-small cell lung cancer.

There are no reviews yet.

Be the first to review “Emrelis (telisotuzumab vedotin-tllv)”